Avobenzone, Octinoxate, Titanium Dioxide
NDC Package 52094-070-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Avobenzone, Octinoxate, Titanium Dioxide is a . Marketed by Grafton Products Corp., this product is identified by NDC 52094-070 and is authorized under FDA application part352.

Identification & Billing

NDC Package Code
52094-070-01
Package Description
3.2 g in 1 CONTAINER
Product Code
52094-070
11-Digit Billing Format
52094007001

Clinical Specifications

Proprietary Name
Avobenzone, Octinoxate, Titanium Dioxide
Dosage Form
-

Regulatory & Marketing

Labeler Name
Grafton Products Corp.
FDA Application #
part352
Marketing Category
OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final.
Start Marketing Date
03-29-2010
End Marketing Date
03-29-2013
Listing Expiration
03-29-2013
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 52094-070-01 identifies a specific commercial package of 3.2 g in 1 container of Avobenzone, Octinoxate, Titanium Dioxide, labeled by Grafton Products Corp.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Grafton Products Corp. on March 29, 2010. The current certification is valid through March 29, 2013.

How is this Grafton Products Corp. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 52094007001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
52094-070-01
11-Digit CMS (5-4-2)
52094-0070-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.